| Business Data Model Data Model |
| Description | A scheduled activity that applies, introduces or otherwise gives medications or other substances to a subject or experimental unit that is anticipated to occur at some time in the future. For example: Administration of methotrexate as part of chemotherapy. |
| Attributes | |
Active Ingredient Dose Qty |
|
| Generalization | |
R_1672 |
|
| Dependencies | |
NONE |
|
| Reverse Dependencies | |
|
|
| Attribute Details |
Active Ingredient Dose Qty
| Description | The quantity of active ingredient anticipated to be administered. For Example: 5 mg This is intended to be a subject-specific quantity. Defined Substance Administration Product Dose can contain a dose expressed in absolute or relative terms (for example, mg or mg/kg). Scheduled Substance Administration Active Ingredient Dose and Performed Substance Administration Product Dose must contain a dose expressed in absolute terms (for example, mg). If the Defined Substance Administration Product Dose was expressed in relative terms (for example, mg/kg), then the absolute dose must have been calculated using one or more observed factors as identified by the Defined Dose Expression Variable Relationship. |
| Data Type | Standards - Data Domains.ddm/Data Domains/Quantity Integer [INTEGER] |
| Is Part Of PrimaryKey | false |
| Is Required | false |
| Is Derived | false |
| Is Surrogate Key | false |
| Generalization Details |
R_1672
| Supertype | Scheduled Activity |
| Subtype | Scheduled Substance Administration |
| Transform As | TABLE |
| Business Data Model Data Model |